Literature DB >> 797044

Bronchodilator effect of delta1-tetrahydrocannabinol administered by aerosol of asthmatic patients.

S J Williams, J P Hartley, J D Graham.   

Abstract

Ten volunteer inpatient asthmatics in a steady state were given a single inhalation of an aerosol (63 mul) delivered in random order, on each of three consecutive days, in the laboratory of a respiratory unit. Before, and for one hour after treatment the pulse, blood pressure (lying and standing), forced expiratory volume in 1 second (FEV1), forced vital capacity (FVC), peak flow rate (PFR), and self-rating mood scales (SRMS) were recorded. Treatments were placebo-ethanol only; delta1-tetrahydrocannabinol (THC) 200 mug in ethanol; or salbutamol 100 mug (Ventolin inhaler), administered double blind. Salbutamol and THC significantly improved ventilatory function. Maximal bronchodilatation was achieved more rapidly with salbutamol, but at 1 hour both drugs were equally effective. No cardiovascular or mood disturbance was detected, and plasma total cannabinoids at 15 minutes were undectable by radioimmunoassay. The mode of action of THC differs from that of sympathomimetic drugs, and it or a derivative may make a suitable adjuvant in the treatment of selected asthmatics.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 797044      PMCID: PMC470501          DOI: 10.1136/thx.31.6.720

Source DB:  PubMed          Journal:  Thorax        ISSN: 0040-6376            Impact factor:   9.139


  10 in total

1.  An inhalation aerosol of delta9-tetrahydrocannabinol.

Authors:  J L Olsen; J W Lodge; B J Shapiro; D P Tashkin
Journal:  J Pharm Pharmacol       Date:  1976-01       Impact factor: 3.765

2.  AN ANALYSIS OF MOOD IN NEUROTICS.

Authors:  D M MCNAIR; M LORR
Journal:  J Abnorm Psychol       Date:  1964-12

3.  THE SPUTUM IN BRONCHIAL ASTHMA: PATHOGNOMONIC PATTERNS.

Authors:  N G SANERKIN; D M EVANS
Journal:  J Pathol Bacteriol       Date:  1965-04

4.  Acute pulmonary physiologic effects of smoked marijuana and oral (Delta)9 -tetrahydrocannabinol in healthy young men.

Authors:  D P Tashkin; B J Shapiro; I M Frank
Journal:  N Engl J Med       Date:  1973-08-16       Impact factor: 91.245

5.  Acute effects of smoked marijuana and oral delta9-tetrahydrocannabinol on specific airway conductance in asthmatic subjects.

Authors:  D P Tashkin; B J Shapiro; I M Frank
Journal:  Am Rev Respir Dis       Date:  1974-04

6.  Single-dose effects of marihuana smoke. Bronchial dynamics and respiratory-center sensitivity in normal subjects.

Authors:  L Vachon; M X FitzGerald; N H Solliday; I A Gould; E A Gaensler
Journal:  N Engl J Med       Date:  1973-05-10       Impact factor: 91.245

7.  Effects of smoked marijuana in experimentally induced asthma.

Authors:  D P Tashkin; B J Shapiro; Y E Lee; C E Harper
Journal:  Am Rev Respir Dis       Date:  1975-09

8.  The development of a radioimmunoassay for cannabinoids in blood and urine.

Authors:  J D Teale; E J Forman; L J King; E M Piall; V Marks
Journal:  J Pharm Pharmacol       Date:  1975-07       Impact factor: 3.765

9.  A trial of oral delta-1-(trans)-tetrahydrocannabinol in reversible airways obstruction.

Authors:  B H Davies; S Radcliffe; A Seaton; J D Graham
Journal:  Thorax       Date:  1975-02       Impact factor: 9.139

10.  Effect of maximal respiratory manoeuvres on bronchial sensitivity of asthmatic patients as compared to normal people.

Authors:  J Orehek; P Gayrard; C Grimaud; J Charpin
Journal:  Br Med J       Date:  1975-01-18
  10 in total
  15 in total

Review 1.  Cannabinoids in clinical practice.

Authors:  E M Williamson; F J Evans
Journal:  Drugs       Date:  2000-12       Impact factor: 9.546

Review 2.  Taming THC: potential cannabis synergy and phytocannabinoid-terpenoid entourage effects.

Authors:  Ethan B Russo
Journal:  Br J Pharmacol       Date:  2011-08       Impact factor: 8.739

3.  Bronchodilator effect of delta1-tetrahydrocannabinol.

Authors:  J P Hartley; S G Nogrady; A Seaton
Journal:  Br J Clin Pharmacol       Date:  1978-06       Impact factor: 4.335

Review 4.  The endocannabinoid system as an emerging target of pharmacotherapy.

Authors:  Pál Pacher; Sándor Bátkai; George Kunos
Journal:  Pharmacol Rev       Date:  2006-09       Impact factor: 25.468

5.  Further studies on the antinociceptive effects of delta 6-THC-7-oic acid.

Authors:  S A Doyle; S H Burstein; W L Dewey; S P Welch
Journal:  Agents Actions       Date:  1990-08

6.  Characterization of the effects of cannabinoids on guinea-pig tracheal smooth muscle tone: role in the modulation of acetylcholine release from parasympathetic nerves.

Authors:  L Spicuzza; E B Haddad; M Birrell; A Ling; D Clarke; P Venkatesan; P J Barnes; M G Belvisi
Journal:  Br J Pharmacol       Date:  2000-08       Impact factor: 8.739

Review 7.  Marijuana. Respiratory tract effects.

Authors:  B E Van Hoozen; C E Cross
Journal:  Clin Rev Allergy Immunol       Date:  1997       Impact factor: 8.667

Review 8.  Pharmacokinetics and pharmacodynamics of cannabinoids.

Authors:  Franjo Grotenhermen
Journal:  Clin Pharmacokinet       Date:  2003       Impact factor: 6.447

9.  Cannabinoids inhibit cholinergic contraction in human airways through prejunctional CB1 receptors.

Authors:  S Grassin-Delyle; E Naline; A Buenestado; C Faisy; J-C Alvarez; H Salvator; C Abrial; C Advenier; L Zemoura; P Devillier
Journal:  Br J Pharmacol       Date:  2014-06       Impact factor: 8.739

10.  A Phase 2 Randomised Clinical Trial Assessing the Tolerability of Two Different Ratios of Medicinal Cannabis in Patients With High Grade Gliomas.

Authors:  Janet Schloss; Judith Lacey; Justin Sinclair; Amie Steel; Michael Sughrue; David Sibbritt; Charles Teo
Journal:  Front Oncol       Date:  2021-05-21       Impact factor: 6.244

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.